{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T13:07:36Z","timestamp":1793452056267,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.brachy.2025.07.013","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T03:58:50Z","timestamp":1758599930000},"page":"833-843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["American Brachytherapy Society (ABS) rectoprostatic gel spacer consensus statement"],"prefix":"10.1016","volume":"24","author":[{"given":"Aurelie","family":"Garant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6780-6541","authenticated-orcid":false,"given":"Craig E.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4097-5107","authenticated-orcid":false,"given":"Martin T.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9988-5571","authenticated-orcid":false,"given":"Emily S.","family":"Weg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2890-5720","authenticated-orcid":false,"given":"Daniel N.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Gahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3773-9963","authenticated-orcid":false,"given":"Khush","family":"Aujla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Hathout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2886-0956","authenticated-orcid":false,"given":"Michael R.","family":"Folkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2025.07.013_bib0001","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"New Engl J Med"},{"key":"10.1016\/j.brachy.2025.07.013_bib0002","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S1470-2045(22)00517-4","article-title":"Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial","volume":"23","author":"Tree","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0003","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"New Engl J Med"},{"key":"10.1016\/j.brachy.2025.07.013_bib0004","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.ijrobp.2008.02.073","article-title":"Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer","volume":"72","author":"Al-Mamgani","year":"2008","journal-title":"Int J Radiat Oncol* Biol* Phys"},{"key":"10.1016\/j.brachy.2025.07.013_bib0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijrobp.2007.06.054","article-title":"Long-term results of the MD Anderson randomized dose-escalation trial for prostate cancer","volume":"70","author":"Kuban","year":"2008","journal-title":"Int J Radiat Oncol* Biol* Phys"},{"key":"10.1016\/j.brachy.2025.07.013_bib0006","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","article-title":"Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial","volume":"8","author":"Dearnaley","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0007","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.radonc.2020.12.017","article-title":"Consequential late effects up to>10 years following primary and postoperative radiotherapy for prostate cancer","volume":"156","author":"Leufgens","year":"2021","journal-title":"Radiother Oncol"},{"issue":"17","key":"10.1016\/j.brachy.2025.07.013_bib0008","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.3390\/cancers15174295","article-title":"Gastrointestinal quality-of-life trajectories after radiotherapy for prostate cancer\u2014Which patients suffer from persisting problems?","volume":"15","author":"Pinkawa","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.brachy.2025.07.013_bib0009","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/pcan.2009.56","article-title":"Time course of late rectal toxicity after radiation therapy for prostate cancer","volume":"13","author":"Odrazka","year":"2010","journal-title":"Prostate Cancer Prostat Dis"},{"key":"10.1016\/j.brachy.2025.07.013_bib0010","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2403365","article-title":"Phase 3 trial of stereotactic body radiotherapy in localized prostate cancer","volume":"391","author":"van As","year":"2024","journal-title":"New Engl J Med"},{"key":"10.1016\/j.brachy.2025.07.013_bib0011","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1470-2045(14)70482-6","article-title":"Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): Acute toxicity results from a randomised non-inferiority phase 3 trial","volume":"16","author":"Aluwini","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0012","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0013","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2025.07.013_bib0014","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ijrobp.2019.03.051","article-title":"Stereotactic body radiation therapy for localized prostate cancer: A systematic review and meta-analysis of over 6,000 patients treated on prospective studies","volume":"104","author":"Jackson","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.07.013_bib0015","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2403365","article-title":"Phase 3 trial of stereotactic body radiotherapy in localized prostate cancer","volume":"391","author":"van As","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.brachy.2025.07.013_bib0016","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1200\/JCO.20.02873","article-title":"Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: Results from the FLAME randomized phase III trial","volume":"39","author":"Kerkmeijer","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110568","article-title":"Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trial","volume":"201","author":"Draulans","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0018","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ijrobp.2016.12.024","article-title":"Continued benefit to rectal separation for prostate radiation therapy: Final results of a phase III trial","volume":"97","author":"Hamstra","year":"2017","journal-title":"Int J Radiat Oncol* Biol* Phys"},{"issue":"4","key":"10.1016\/j.brachy.2025.07.013_bib0019","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/jamaoncol.2022.7592","article-title":"Hyaluronic acid spacer for hypofractionated prostate radiation therapy: A randomized clinical trial","volume":"9","author":"Mariados","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijrobp.2021.03.025","article-title":"A multi-institutional phase 2 trial of high-dose SAbR for prostate cancer using rectal spacer","volume":"111","author":"Folkert","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.brachy.2025.07.013_bib0021","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3390\/cancers16081472","article-title":"In curative stereotactic body radiation therapy for prostate cancer, there is a high possibility that 45 gy in five fractions will not Be tolerated without a hydrogel spacer","volume":"16","author":"Sawayanagi","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.brachy.2025.07.013_bib0022","first-page":"E588","article-title":"Current topics in radiotherapy for genitourinary cancers: Consensus statements of the Genitourinary Radiation Oncologists of Canada","volume":"14","author":"Morgan","year":"2020","journal-title":"Can Urolog Assoc J"},{"key":"10.1016\/j.brachy.2025.07.013_bib0023","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1515\/raon-2016-0036","article-title":"Interdisciplinary consensus statement on indication and application of a hydrogel spacer for prostate radiotherapy based on experience in more than 250 patients","volume":"50","author":"M\u00fcller","year":"2016","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0024","doi-asserted-by":"crossref","first-page":"e060506","DOI":"10.1136\/bmjopen-2021-060506","article-title":"Delphi study to identify consensus on patient selection for hydrogel rectal spacer use during radiation therapy for prostate cancer in the UK","volume":"12","author":"Payne","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.brachy.2025.07.013_bib0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1470-2045(20)30639-2","article-title":"Considering benefit and risk before routinely recommending SpaceOAR","volume":"22","author":"Hall","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0026","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/iju5.12209","article-title":"Spontaneous remission of rectal ulcer associated with SpaceOAR","volume":"3","author":"Imai","year":"2020","journal-title":"IJU Case Rep"},{"key":"10.1016\/j.brachy.2025.07.013_bib0027","doi-asserted-by":"crossref","first-page":"e229143","DOI":"10.1136\/bcr-2018-229143","article-title":"Abscess formation following hydrogel spacer for prostate cancer radiotherapy: A rare complication","volume":"12","author":"Hoe","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.brachy.2025.07.013_bib0028","first-page":"647","article-title":"A case of migration of a hydrogel spacer for radiotherapy into the pulmonary artery","volume":"77","author":"Kojima","year":"2023","journal-title":"Acta Med Okayama"},{"issue":"3","key":"10.1016\/j.brachy.2025.07.013_bib0029","doi-asserted-by":"crossref","first-page":"rjad163","DOI":"10.1093\/jscr\/rjad163","article-title":"The case of the missing spacer!","volume":"2023","author":"Boerkamp","year":"2023","journal-title":"J Surg Case Rep"},{"key":"10.1016\/j.brachy.2025.07.013_bib0030","article-title":"Hydrogel spacer rectal wall infiltration associated with severe rectal injury and related complications after dose intensified prostate cancer stereotactic ablative radiation therapy","volume":"6","author":"McLaughlin","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0031","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.urology.2023.09.016","article-title":"Real-world complications of the SpaceOAR hydrogel spacer: A review of the manufacturer and user facility device experience database","volume":"183","author":"Fernandez","year":"2023","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2025.07.013_bib0032","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.urology.2023.12.034","article-title":"Major complications and adverse events related to use of SpaceOAR hydrogel for prostate cancer radiotherapy","volume":"188","author":"Millot","year":"2024","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2025.07.013_bib0033","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1378\/chest.129.1.174","article-title":"Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College of Chest Physicians task force","volume":"129","author":"Guyatt","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.brachy.2025.07.013_bib0034","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.urology.2013.07.014","article-title":"Learning curve in the application of a hydrogel spacer to protect the rectal wall during radiotherapy of localized prostate cancer","volume":"82","author":"Pinkawa","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2025.07.013_bib0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/iju.15140","article-title":"Safety of hydrogel spacers for rectal wall protection in patients with prostate cancer: A retrospective analysis of 200 consecutive cases","volume":"30","author":"Yamaguchi","year":"2023","journal-title":"Int J Urol"},{"issue":"12","key":"10.1016\/j.brachy.2025.07.013_bib0036","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/pros.24744","article-title":"Efficacy of a hydrogel spacer for improving quality of life in patients with prostate cancer undergoing low-dose-rate brachytherapy alone or in combination with intensity-modulated radiotherapy: An observational study using propensity score matching","volume":"84","author":"Nakai","year":"2024","journal-title":"Prostate"},{"key":"10.1016\/j.brachy.2025.07.013_bib0037","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.brachy.2023.07.005","article-title":"Cs-131 prostate brachytherapy boost and effect of hydrogel rectal spacer on long-term patient-reported rectal bleeding and bowel quality of life","volume":"22","author":"Abdelhakiem","year":"2023","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.07.013_bib0038","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bju.15572","article-title":"Influence of hydrogel spacer placement with prostate brachytherapy on rectal and urinary toxicity","volume":"129","author":"Teyateeti","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.brachy.2025.07.013_bib0039","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.brachy.2020.09.018","article-title":"The impact of a rectal hydrogel spacer on dosimetric and toxicity outcomes among patients undergoing combination therapy with external beam radiotherapy and low-dose-rate brachytherapy","volume":"20","author":"Nehlsen","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.07.013_bib0040","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/1754-9485.12882","article-title":"High dose rate brachytherapy boost for prostate cancer: Biochemical control and the impact of transurethral resection of the prostate and hydrogel spacer insertion on toxicity outcomes","volume":"63","author":"Chao","year":"2019","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0041","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5114\/jcb.2019.82836","article-title":"Improving rectal dosimetry for patients with intermediate and high-risk prostate cancer undergoing combined high-dose-rate brachytherapy and external beam radiotherapy with hydrogel space","volume":"11","author":"Chao","year":"2019","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2025.07.013_bib0042","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.brachy.2023.06.003","article-title":"A dosimetric analysis of rectal hydrogel spacer use in patients with recurrent prostate cancer undergoing salvage high-dose-rate brachytherapy","volume":"22","author":"Lee","year":"2023","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.07.013_bib0043","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ijrobp.2023.09.051","article-title":"Long-term quality-of-life outcomes after prostate radiation therapy with or without high-dose-rate brachytherapy boost: Post hoc analysis of TROG 03.04 RADAR","volume":"119","author":"Ong","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.07.013_bib0044","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1089\/end.2019.0431","article-title":"Major complications and adverse events related to the injection of the SpaceOAR hydrogel system before radiotherapy for prostate cancer: Review of the manufacturer and user facility device experience database","volume":"33","author":"Aminsharifi","year":"2019","journal-title":"J Endourol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.prro.2016.10.004","article-title":"Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall","volume":"7","author":"Fischer-Valuck","year":"2017","journal-title":"Pract Radiat Oncol"},{"issue":"12","key":"10.1016\/j.brachy.2025.07.013_bib0046","article-title":"Depth of Hydrogel spacer rectal wall infiltration (RWI) was not associated with rectal toxicity: Results from a randomized prospective trial","volume":"9","author":"Grossman","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.870388","article-title":"Case report: Reversal of hyaluronic acid rectal wall infiltration with hyaluronidase","volume":"12","author":"Hong","year":"2022","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.brachy.2025.07.013_bib0048","first-page":"S3","article-title":"Long-term analysis of NRG Oncology RTOG 0415: A randomized phase III noninferiority study comparing two fractionation schedules in patients with low-risk prostate cancer","volume":"117","author":"Lee","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0049","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.0039","article-title":"Effect of standard vs dose-escalated radiation therapy for patients with intermediate-risk prostate cancer: The NRG Oncology RTOG 0126 randomized clinical trial","volume":"4","author":"Michalski","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0050","doi-asserted-by":"crossref","first-page":"17383","DOI":"10.18632\/oncotarget.14798","article-title":"Rectal\/urinary toxicity after hypofractionated vs conventional radiotherapy in low\/intermediate risk localized prostate cancer: Systematic review and meta analysis","volume":"8","author":"Di Franco","year":"2017","journal-title":"Oncotarget"},{"issue":"3 Supplement","key":"10.1016\/j.brachy.2025.07.013_bib0051","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1016\/j.ijrobp.2021.07.1393","article-title":"Quality metric to assess adequacy of Hydrogel rectal spacer placement for prostate radiotherapy and association of metric score with dosimetric and gastrointestinal toxicity outcomes","volume":"111","author":"Grossman","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"192","key":"10.1016\/j.brachy.2025.07.013_bib0052","article-title":"A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy","volume":"13","author":"Hwang","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0053","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1016\/j.prro.2023.11.010","article-title":"Evaluating the quality-of-life effect of apical spacing with hyaluronic acid prior to hypofractionated prostate radiation therapy: A secondary analysis","volume":"14","author":"King","year":"2024","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0054","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1089\/end.2019.0431","article-title":"Major complications and adverse events related to the injection of the SpaceOAR hydrogel system before radiotherapy for prostate cancer: Review of the manufacturer and user facility device experience database","volume":"33","author":"Aminsharifi","year":"2019","journal-title":"J Endourol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.urology.2023.09.016","article-title":"Real-world complications of the SpaceOAR Hydrogel spacer: A review of the manufacturer and user facility device experience database","volume":"183","author":"Fernandez","year":"2024","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2025.07.013_bib0056","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-060506","article-title":"Delphi study to identify consensus on patient selection for hydrogel rectal spacer use during radiation therapy for prostate cancer in the UK","volume":"12","author":"Payne","year":"2022","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.brachy.2025.07.013_bib0057","first-page":"E588","article-title":"Current topics in radiotherapy for genitourinary cancers: Consensus statements of the Genitourinary Radiation Oncologists of Canada","volume":"14","author":"Morgan","year":"2020","journal-title":"Can Urolog Assoc J"},{"issue":"5","key":"10.1016\/j.brachy.2025.07.013_bib0058","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ijrobp.2016.09.050","article-title":"Continued benefit to rectal separation for prostate RT: Final results of a phase III trial","volume":"96","author":"Hamstra","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.brachy.2025.07.013_bib0059","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ijrobp.2015.04.030","article-title":"Hydrogel spacer prospective multicenter randomized controlled pivotal trial: Dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy","volume":"92","author":"Mariados","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.07.013_bib0060","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1515\/raon-2016-0036","article-title":"Interdisciplinary consensus statement on indication and application of a hydrogel spacer for prostate radiotherapy based on experience in more than 250 patients","volume":"50","author":"Muller","year":"2016","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0061","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2017.35.6_suppl.69","article-title":"Evaluation of sexual function on a randomized trial of a prostate rectal spacer","volume":"35","author":"Hamstra","year":"2017","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.brachy.2025.07.013_bib0062","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/pros.24525","article-title":"Proton therapy for high-risk prostate cancer: Results from the Proton Collaborative Group PCG 001-09 prospective registry trial","volume":"83","author":"Hasan","year":"2023","journal-title":"Prostate"},{"key":"10.1016\/j.brachy.2025.07.013_bib0063","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13014-022-02025-2","article-title":"Dosimetric feasibility of moderately hypofractionated\/dose escalated radiation therapy for localised prostate cancer with intensity-modulated proton beam therapy using simultaneous integrated boost (SIB-IMPT) and impact of hydrogel prostate-rectum spacer","volume":"17","author":"Ahmad Khalil","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0064","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.brachy.2019.11.002","article-title":"Rectal spacing, prostate coverage, and periprocedural outcomes after hydrogel spacer injection during low-dose-rate brachytherapy implantation","volume":"19","author":"Kahn","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.07.013_bib0065","doi-asserted-by":"crossref","first-page":"605","DOI":"10.5114\/jcb.2021.112110","article-title":"Impact of hydrogel and hyaluronic acid rectal spacer on rectal dosimetry and toxicity in low-dose-rate prostate brachytherapy: A multi-institutional analysis of patients' outcomes","volume":"13","author":"Lin","year":"2021","journal-title":"J Contemp Brachyther"},{"key":"10.1016\/j.brachy.2025.07.013_bib0066","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.brachy.2017.11.006","article-title":"Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103","volume":"17","author":"Taggar","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.07.013_bib0067","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.brachy.2014.05.001","article-title":"Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results","volume":"13","author":"Mahal","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.07.013_bib0068","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4081\/aiua.2017.2.106","article-title":"Safety of transrectal ultrasound-guided prostate biopsy in patients affected by Crohn's disease","volume":"89","author":"Dell'Atti","year":"2017","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.brachy.2025.07.013_bib0069","article-title":"Successful use of absorbable hydrogel rectal spacers (SpaceOAR) before salvage radiation therapy after previous prostate cryotherapy","volume":"6","author":"Applewhite","year":"2021","journal-title":"Adv Radiat Oncol"},{"issue":"5","key":"10.1016\/j.brachy.2025.07.013_bib0070","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.brachy.2023.06.003","article-title":"A dosimetric analysis of rectal hydrogel spacer use in patients with recurrent prostate cancer undergoing salvage high-dose-rate brachytherapy","volume":"22","author":"Lee","year":"2023","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.07.013_bib0071","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.brachy.2022.07.009","article-title":"Focal injection of a radiopaque viscous spacer before focal brachytherapy as re-irradiation for locally recurrent prostate cancer","volume":"21","author":"Pinkawa","year":"2022","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.07.013_bib0072","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13014-021-01839-w","article-title":"Salvage re-irradiation using stereotactic body radiation therapy for locally recurrent prostate cancer: The impact of castration sensitivity on treatment outcomes","volume":"16","author":"Lewin","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0073","article-title":"Stereotactic prostate focal reirradiation therapy for local recurrence: Preliminary results of Hartmann Oncology Radiotherapy Group","volume":"1","author":"Scher","year":"2019","journal-title":"BJR Open"},{"issue":"3","key":"10.1016\/j.brachy.2025.07.013_bib0074","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.prro.2016.10.004","article-title":"Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall","volume":"7","author":"Fischer-Valuck","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.urology.2023.09.031","article-title":"Effect of transperineal versus transrectal prostate biopsy on the quality of hydrogel spacer placement in men prior to radiation therapy for prostate cancer","volume":"182","author":"Rezaee","year":"2023","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.brachy.2025.07.013_bib0076","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-019-1248-6","article-title":"Rectum-spacer related acute toxicity - endoscopy results of 403 prostate cancer patients after implantation of gel or balloon spacers","volume":"14","author":"Schorghofer","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0077","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0360-3016(03)00784-3","article-title":"Radical prostatectomy, external beam radiotherapy <72 gy, external beam radiotherapy >or =72 gy, permanent seed implantation, or combined seeds\/external beam radiotherapy for stage T1-T2 prostate cancer","volume":"58","author":"Kupelian","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.07.013_bib0078","doi-asserted-by":"crossref","first-page":"E422","DOI":"10.1097\/JU.0000000000003262.09","article-title":"Real world assessment of Mri predictors of rectal complications following transperineal spaceoar hydrogel insertion","volume":"209","author":"Kam","year":"2023","journal-title":"Journal of Urology"},{"key":"10.1016\/j.brachy.2025.07.013_bib0079","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/iju5.12209","article-title":"Spontaneous remission of rectal ulcer associated with SpaceOAR((R)) hydrogel insertion in radiotherapy for prostate cancer","volume":"3","author":"Imai","year":"2020","journal-title":"IJU Case Rep"},{"key":"10.1016\/j.brachy.2025.07.013_bib0080","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12894-020-00767-3","article-title":"The use of hyperbaric oxygen to treat actinic rectal fistula after SpaceOAR use and radiotherapy for prostate cancer: A case report","volume":"20","author":"Kashihara","year":"2020","journal-title":"BMC Urol"},{"key":"10.1016\/j.brachy.2025.07.013_bib0081","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/UPJ.0000000000000071","article-title":"A case of rectal ulcer during intensity modulated radiotherapy for prostate cancer using hydrogel spacer","volume":"7","author":"Dinh","year":"2020","journal-title":"Urol Pract"},{"key":"10.1016\/j.brachy.2025.07.013_bib0082","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-206931","article-title":"Rectal ulcer associated with SpaceOAR hydrogel insertion during prostate brachytherapy","volume":"2014","author":"Teh","year":"2014","journal-title":"BMJ Case Rep"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125002867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125002867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:29:22Z","timestamp":1761121762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472125002867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1538472125002867"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2025.07.013","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"American Brachytherapy Society (ABS) rectoprostatic gel spacer consensus statement","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2025.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of American Brachytherapy Society.","name":"copyright","label":"Copyright"}]}}